(2026). Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2). Journal of Hepatocellular Carcinoma.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)."
Journal of Hepatocellular Carcinoma 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)."
Journal of Hepatocellular Carcinoma, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.